Darling TN et al. |
Treatment of Mycobacterium haemophilum infection with an antibiotic regimen including clarithromycin. |
1994 |
Br. J. Dermatol. |
pmid:7918014
|
Domschke W |
Omeprazole, Helicobacter pylori, and gastritis. |
1994 |
J. Gastroenterol. |
pmid:7921141
|
Geraci AJ |
Empiric antibiotics in sinusitis. |
1994 |
Arch Fam Med |
pmid:7921288
|
Rust GS |
Multicenter comparison of clarithromycin and amoxicillin. |
1994 |
Arch Fam Med |
pmid:7921290
|
Sieber CC et al. |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?]. |
1994 |
Schweiz Med Wochenschr |
pmid:8091165
|
Böttger EC |
Resistance to drugs targeting protein synthesis in mycobacteria. |
1994 |
Trends Microbiol. |
pmid:7850212
|
Thijs JC et al. |
Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection. |
1994 |
Aliment. Pharmacol. Ther. |
pmid:8186339
|
Logan RP et al. |
Eradication of Helicobacter pylori with clarithromycin and omeprazole. |
1994 |
Gut |
pmid:8150340
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Goldman RC et al. |
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979278
|
Roblin PM et al. |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979292
|
|
[Recent advances in macrolide antibiotics: focused on clarithromycin. Discussion]. |
1994 |
Jpn J Antibiot |
pmid:7990251
|
Tsang KW et al. |
The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration. |
1994 |
J. Antimicrob. Chemother. |
pmid:8182010
|
Sundberg L and Cederberg A |
Penetration of clarithromycin and its 14-hydroxy metabolite into middle ear effusion in children with secretory otitis media. |
1994 |
J. Antimicrob. Chemother. |
pmid:8182011
|
|
[Zeclar, a new antibiotic (clarithromycin 250 mg from Abbott laboratories]. |
1994 |
Rev Infirm |
pmid:7652424
|
Marco ML et al. |
[Rhodococcus equi pneumonia in patients with AIDS]. |
1994 |
Arch. Bronconeumol. |
pmid:7827773
|
Laing RB et al. |
New antimicrobials against Mycobacterium marinum infection. |
1994 |
Br. J. Dermatol. |
pmid:7857853
|
Spiegl PV and Feiner CM |
Mycobacterium phlei infection of the foot: a case report. |
1994 |
Foot Ankle Int |
pmid:7894643
|
Rapp RP et al. |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. |
1994 |
Ann Pharmacother |
pmid:7849341
|
Walker KJ et al. |
Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7811010
|
Price DA et al. |
Clinical response to the addition of clarithromycin in Pneumocystis carinii pneumonia refractory to high dose co-trimoxazole. |
1994 |
J. Antimicrob. Chemother. |
pmid:7814298
|
Tahara RW et al. |
The question of clarithromycin: a first-line drug for sinusitis? |
1994 |
Arch Fam Med |
pmid:7818657
|
Pustorino S et al. |
[Effects of intravenous administration of clarithromycin on plasma levels of gastrin and group I pepsinogen]. |
1994 |
Clin Ter |
pmid:7820984
|
Alder J et al. |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine. |
1994 |
J. Acquir. Immune Defic. Syndr. |
pmid:7932081
|
Ferrari SL et al. |
The interaction between clarithromycin and cyclosporine in kidney transplant recipients. |
1994 |
Transplantation |
pmid:7940695
|
Wüst J and Hardegger U |
Penetration of clarithromycin into human saliva. |
1993 Sep-Oct |
Chemotherapy |
pmid:8370320
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Ohmori S et al. |
Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats. |
1993 Mar-Apr |
Drug Metab. Dispos. |
pmid:8097709
|
Wallace RJ et al. |
Drug intolerance to high-dose clarithromycin among elderly patients. |
1993 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:8477575
|
Adam D |
Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis. |
1993 Jul-Aug |
Infection |
pmid:8225636
|
Coles SJ et al. |
A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 Jul-Aug |
Infection |
pmid:8225637
|
Miller CA |
Infections, resistant microbes, and older adults. |
1993 Jan-Feb |
Geriatr Nurs |
pmid:8383085
|
Ritchie DJ et al. |
In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. |
1993 Jan-Feb |
Clin Ther |
pmid:8458040
|
Albani F et al. |
Clarithromycin-carbamazepine interaction: a case report. |
1993 Jan-Feb |
Epilepsia |
pmid:8422851
|
Sader HS et al. |
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. |
1993 Aug-Sep |
Diagn. Microbiol. Infect. Dis. |
pmid:8243035
|
Maurin M and Raoult D |
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8109928
|
Hakkarinen WD |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482929
|
Luger SW |
Clarithromycin vs penicillin. |
1993 |
J Fam Pract |
pmid:8482930
|
Neu HC and Chick TW |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. |
1993 |
Chest |
pmid:8222794
|
Kodama R et al. |
[Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. |
1993 |
Nippon Rinsho |
pmid:8283646
|
Wettengel R et al. |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8360133
|
Nakashio S et al. |
[Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material]. |
1993 |
Jpn J Antibiot |
pmid:8360978
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Graham DY et al. |
Clarithromycin for the eradication of Helicobacter pylori. |
1993 |
J. Clin. Gastroenterol. |
pmid:8331260
|
Esvant H et al. |
[Primary prophylaxis of cerebral toxoplasmosis in AIDS with clarithromycin]. |
1993 |
Presse Med |
pmid:8337221
|
Mazzei T et al. |
Chemistry and mode of action of macrolides. |
1993 |
J. Antimicrob. Chemother. |
pmid:7683018
|
Lazard T et al. |
Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684213
|
Emori M et al. |
Therapeutic efficacy of the benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. |
1993 |
Antimicrob. Agents Chemother. |
pmid:7684214
|